Optimizing HIV care with pharmacist-driven proactive e-consults to improve lung health
Official title: Optimizing Medications and Lung Health in People with HIV through Pharmacist-led Proactive E-Consults (OPTIMIZE Lung-HIV)
Funded at Seattle Inst for Biomedical/clinical Res · NIH-11393183 · Data updated 2026-11-12
A pharmacist-led program helps people with HIV get better pneumonia prevention and lung care through proactive electronic consultations.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Seattle Inst for Biomedical/clinical Res NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | August 15, 2025 |
| Project end | May 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $798,250 |
| NIH project number | 5R01HL179905-02 |
| Project ID | NIH-11393183 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with HIV who are at risk for pneumonia and receive care in participating centers.
✕Less likely to help
Patients not receiving care at participating sites or not meeting study criteria may not experience direct benefits.
What this research studies
People with HIV have a higher risk of pneumonia and related complications. This project tests a pharmacist-driven e-consult approach added to usual care to improve vaccinations, smoking cessation help, and reducing inappropriate medications. The study builds on a previous pharmacist-led model in the Veterans Health Administration and aims to scale it across centers. It will measure whether this proactive approach improves guideline-concordant care and lowers pneumonia risk.
Why it matters
Potential benefit: If successful, patients with HIV could receive better prevention of pneumonia and fewer medication-related risks through more coordinated, pharmacist-led care.
How similar studies have gone: Related pharmacist-driven e-consult programs in COPD care within HIV populations showed improved quality of care and are a promising foundation for this study.
Where this research is happening
-
Seattle Inst for Biomedical/clinical Res
Seattle, United States Active
Researchers
- Principal investigator: Crothers, Kristina Anne — Seattle Inst for Biomedical/clinical Res
- Study coordinator: Crothers, Kristina Anne
Related research
Other NIH-funded projects on the same topics.
-
Military Service–Linked ALS Risk in U.S. Veterans
This NIH grant investigates why U.S. veterans get ALS more often, by studying military exposures and health records to identify potential risk factors.
-
Targeting MSUT2 with small molecules to slow tau-related dementia
Aims to test whether small molecules that block MSUT2’s interaction with RNA can slow or reverse tau-related brain damage in people affected by Alzheimer’s disease and related dementias.
-
SPOP's role in tau-related brain disease
Researchers are studying how a protein called SPOP affects tau-related brain damage in Alzheimer's-type conditions, using a small worm model to mirror human disease and look for ways to protect brain cells.
-
Comparing medicines and weight-loss surgery for liver disease linked to metabolic problems
This program looks at how two drugs and bariatric surgery work for adults with metabolic dysfunction–associated steatohepatitis (MASH) and liver fibrosis.
-
Dementia with Lewy Bodies Consortium
A national research effort to better understand and diagnose Lewy body dementia by studying biomarkers and patient data over time.
-
Post-TBI Sleep Problems and Alzheimer’s/CTE Brain Changes
This grant studies whether sleep disruption after a traumatic brain injury increases the risk of Alzheimer’s disease and related brain changes later on, with a focus on people who’ve had mTBI.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.